Novel therapy will have room to grow at USD Discovery District
After two decades in development, a unique drug and device combination for a hard-to-treat disease will have a new home at the USD Discovery District.
After two decades in development, a unique drug and device combination for a hard-to-treat disease will have a new home at the USD Discovery District.
Three companies with a huge range of promising technologies will be part of a panel discussion June 15 at Breakthrough, an annual summit and banquet for South Dakota Biotech.
A technology to treat peripheral vascular disease that was developed in a Sioux Falls lab and acquired by Avera has been approved for clinical trials.